Related Experiment Video
Updated: Jun 9, 2025

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
T-Cell Epitope-Based Vaccines: A Promising Strategy for Prevention of Infectious Diseases
Xin Song1, Yongfeng Li1, Hongxia Wu1
1State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.
T-cell epitope-based vaccines offer a promising approach for infectious diseases, providing enhanced efficacy and safety over traditional methods. This review compares epitope prediction and vaccine development strategies, addressing current challenges.
Area of Science:
- Vaccinology
- Immunology
- Bioinformatics
Background:
- Traditional vaccines face limitations in controlling certain infectious diseases.
- Novel vaccine strategies, including T-cell epitope-based vaccines, are emerging as powerful tools.
- These vaccines utilize specific immunogenic peptides to induce protective T-cell responses.
Purpose of the Study:
- To review and compare methods for predicting and identifying T-cell epitopes.
- To explore diverse T-cell epitope-based vaccine development approaches.
- To discuss challenges and future perspectives in epitope-based vaccinology.
Main Methods:
- Bioinformatic prediction of T-cell epitopes.
- Experimental validation of predicted epitopes.
- Comparative analysis of different epitope-based vaccine development strategies.
Main Results:
- Integration of bioinformatic prediction and experimental validation enables efficient and precise T-cell epitope screening.
- Various T-cell epitope-based vaccine development approaches have distinct advantages and disadvantages.
- Key challenges and future opportunities in the field were identified.
Conclusions:
- T-cell epitope-based vaccines demonstrate superior efficacy and safety profiles.
- Optimized prediction and validation methods are crucial for successful vaccine design.
- This review provides insights for developing effective vaccines against challenging diseases.
More Related Videos
07:59A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
Published on: March 25, 2014
08:10Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
Published on: November 28, 2018
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations
Cross-reactivity
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...